Avion Wealth’s Annovis Bio ANVS Stock Holding History

Avion Wealth’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	229	–	–	﹤0.01%	1222
2025 Q4	$0	Buy	+229	New	+$688	﹤0.01%	1211

Other funds holding ANVS

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Avion Wealth's ANVS Position: Q1 2026 in Review

Avion Wealth held its Annovis Bio (ANVS) position steady in Q1 2026 at 229 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

Avion Wealth first reported a position in ANVS in Q4 2025 and has held it in 2 quarters since. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

Avion Wealth held 229 shares of Annovis Bio worth $0 as of Q1 2026.
Avion Wealth left its Annovis Bio share count unchanged in Q1 2026.
Annovis Bio made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #1222 holding.
Avion Wealth first reported a position in Annovis Bio in Q4 2025 and has held it in 2 quarters since.
56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.